A detailed history of Park Place Capital Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Park Place Capital Corp holds 468 shares of TECH stock, worth $29,282. This represents 0.01% of its overall portfolio holdings.

Number of Shares
468
Previous 612 23.53%
Holding current value
$29,282
Previous $31,000 16.13%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$49.87 - $58.78 $7,181 - $8,464
-144 Reduced 23.53%
468 $26,000
Q2 2025

Jul 17, 2025

BUY
$46.66 - $58.38 $6,719 - $8,406
144 Added 30.77%
612 $31,000
Q3 2024

Oct 08, 2024

SELL
$70.96 - $82.35 $3,689 - $4,282
-52 Reduced 10.0%
468 $37,000
Q4 2023

Jan 24, 2024

SELL
$52.83 - $78.22 $1,690 - $2,503
-32 Reduced 5.8%
520 $40,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $44,529 - $194,464
552 New
552 $46,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.45B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.